Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 52, n° 3S
page P11 (mars 2005)
Doi : 10.1016/j.jaad.2004.10.057
A new alternative in the treatment of superficial inflammatory lesions in acne patients during summer
 

Brigitte Dreno, MD, A. Khamari, MD, CHU Hospital Nantes, Nantes, France; Jean-Paul Ortonne, MD, CHU Hospital Nice, Nice, France; Andre Rougier, PhD, La Roche-Posay Pharmaceutical Laboratories, Asnières, France


 P103
Dr. Rougier is Scientific Director for La Roche-Posay Pharmaceutical Laboratories.
Supported by La Roche-Posay Pharmaceutical Laboratories


Top of the page

© 2005  American Academy of Dermatology, Inc.@@#104156@@